In this issue of Cancer Cell, Qu et al. describe the chromatin accessibility profiles of cutaneous T cell lymphoma, with dynamic assessments of response and resistance to histone deacetylase inhibitor therapy. Their “personal regulome” analysis framework reveals chromatin features that may be predictive of clinical response to epigenetic therapy.
CITATION STYLE
Ott, C. J., & Wu, C. J. (2017, July 10). HDAC Inhibitors Finally Open Up: Chromatin Accessibility Signatures of CTCL. Cancer Cell. Cell Press. https://doi.org/10.1016/j.ccell.2017.06.008
Mendeley helps you to discover research relevant for your work.